Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement.

Biocon Ltd has broken out of the Symmetrical Triangle formation on daily charts, suggesting a potential rise in stock price.

Nifty 50, India’s benchmark index, closed 92 points higher on Tuesday, ending its two-day losing streak to settle at ...

Biocon Biologics completes one-year as an integrated global biosimilars enterprise: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:30 Hrs [IST] Biocon Biologics in its first ...

MUMBAI: Indian shares rose on Tuesday, led by a rally in energy stocks after a brokerage upgraded ONGC and as Reliance recovered some of its losses from the previous session. The Nifty 50 gained 0.39% ...

Biocon’s subsidiary, Biocon Biologics Limited (BBL), has announced the completion of its first year as a fully integrated ...

Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with ...

Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, ...

Biocon's biosimilar Ustekinumab receives regulatory approval in Japan, with Yoshindo Inc. handling commercialization and ...

Zomato slips on Jefferies' downgrade, Biocon rallies on USFDA approval and Jefferies upgrade, ONGC gains as CLSA names it a ...